Standard dose versus low dose non–vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials-Reference-Cited by-同舟云学术

Standard dose versus low dose non–vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials

Published:2016-12 Issue:12 Volume:13 Page:2340-2347
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Wang Kang-Ling,Giugliano Robert P.,Goto Shinya,Chiu Chun-Chih,Lin Chun-Yi,Lai En-Yu,Chiang Chern-En

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference35 articles.

1. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

2. The risks of risk scores for stroke risk assessment in atrial fibrillation;Nielsen;Thromb Haemost,2015

3. Stroke prevention in atrial fibrillation: an Asian stroke perspective;Tse;Heart Rhythm,2013

4. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

5. Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: the GLORIA-AF registry, phase II;Huisman;Am J Med,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban;Annals of Hematology;2024-05-07

2. Atrial Fibrillation Known Prior to Stroke and Preceding Oral Anticoagulant Therapy;INT J GERONTOL;2023

3. Factors Predicting Stroke Recurrence in Stroke Patients with Atrial Fibrillation;INT J GERONTOL;2022

4. Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis;The Anatolian Journal of Cardiology;2022-06-02

5. Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis;Cardiology Research and Practice;2022-03-07